Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you.
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities.
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless.
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest.
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions.
- Other sectors: From media to academia, we work with sectors as diverse as our data.
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on:
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge.
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them.
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - CIGB-128 in Brain Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CIGB-128 in Brain Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CIGB-128 in Brain TumorDrug Details:CIGB-128 is under investigation for the treatment of Coronavirus...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Influenza Vaccine 2 in Pandemic Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza Vaccine 2 in Pandemic Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza Vaccine 2 in Pandemic InfluenzaDrug Details:Vaccine is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - RZ-358 in Hyperinsulinemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RZ-358 in Hyperinsulinemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RZ-358 in HyperinsulinemiaDrug Details: RZ-358 (XOMA-358) is under development for the treatment of hyperinsulinemic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Oxymorphone ER in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oxymorphone ER in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Oxymorphone ER in PainDrug Details:Oxymorphone is under development for the treatment for moderate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ulixertinib in Extrahepatic Bile Duct Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulixertinib in Extrahepatic Bile Duct Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ulixertinib in Extrahepatic Bile Duct CancerDrug Details:Ulixertinib (BVD-523) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Thymic Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Thymic Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Imifoplatin in Thymic CarcinomaDrug Details:PT-112 is under development for the treatment of advanced...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Baltaleucel-T in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Baltaleucel-T in Nasopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Baltaleucel-T in Nasopharyngeal CancerDrug Details:Baltaleucel-T (CMD-003) is under investigation for the treatment of nasopharyngeal...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cellgram-LC in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellgram-LC in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cellgram-LC in Liver CirrhosisDrug Details:Livercellgram is under development for the treatment of alcoholic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Intestinal Schistosomiasis Vaccine in Intestinal Schistosomiasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Intestinal Schistosomiasis Vaccine in Intestinal Schistosomiasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Intestinal Schistosomiasis Vaccine in Intestinal SchistosomiasisDrug Details:Vaccine candidate (SchistoShield) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Efinopegdutide in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efinopegdutide in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Efinopegdutide in Non-Alcoholic Steatohepatitis (NASH)Drug Details: Efinopegdutide is under development for the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.